Leukemia Clinical Trials in Dallas

Showing 801-820 of 1,246 trials

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

NCT02785250

T cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the safety and potential immune-modulating activity of the combination of these agents.

Recurrent Epithelial Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Peritoneal Cancer

ImmunoVaccine Technologies, Inc. (IMV Inc.)85 participantsStarted Apr 2016

Palo Alto, California, United States • Augusta, Georgia, United States • New York, New York, United States +6 more locations

COMPLETEDPhase 3< 1 mile

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

NCT01492101

The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously treated with cytotoxic chemotherapy regimens. The primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of Physician's Choice selected from a list of seven single-agent intravenous therapies.

Locally Recurrent Breast CancerMetastatic Breast Cancer

Nektar Therapeutics852 participantsStarted Dec 2011

Flagstaff, Arizona, United States • Burbank, California, United States • Los Angeles, California, United States +150 more locations

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Leukemia Trials in Other Cities

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Selecting a Favorable KIR Donor in Unrelated HCT for AML

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

Other Conditions in Dallas